Peripheral Venous Pressure (PVP) Trial
ConditionCongestive Heart Failure
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorWake Forest University Health Sciences
About this trial
The purpose of the study is to determine if there is a reduction in the length of stay and rates of rehospitalization for patients diagnosed with congestive heart failure when physicians are provided daily measurements of peripheral venous pressure versus no daily measurements of peripheral venous pressure.
Eligibility criteria
Qualifiers
Patients with minimum 3-month history of Congestive Heart Failure admitted to Aurora St. Luke's Medical Center with acute decompensation
English speaking only
Disqualifiers
Patients who do not already have a peripheral IV line inserted
Patients whose IV line cannot be transduced
Patients with current or past vein thrombosis in the arm used to measure the pressure or with history of recurrent (>1) pulmonary embolism
Patients with active thrombophlebitis in the arm
Trial design
Treatments tested in this trial
- peripheral venous pressure measurements
- standard clinical care
Treatment groups
600 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov